October 2023: A Significant Shift in FAA Policy In September and October 2023, the FAA introduced major changes that streamlined medical certification protocol and expanded eligibility for certain weight loss medications, including GLP-1 receptor agonists such as: Semaglutide (Wegovy) Liraglutide (Saxenda) Tirzepatide (Zepbound, Mounjaro) Rather than issuing blanket prohibitions, the FAA established specific pathways for certification (including a fast-track), observation periods, documentation requirements and ongoing monitoring
Lcmodel & lcmgui users manual
This underscores the importance of identifying additional clinical or biological factors that can better predict glycaemic response to GLP-1 RA treatment
Weight loss surgery Don't undergo weight loss surgery if you don't have to
Anti-Aging: Thanks to the better collagen turnover in the body, it can potentially lead to better skin elasticity and vitality
GLP-1 medications can be safe and effective when prescribed for appropriate patients and monitored by a healthcare provider, medical experts say